000			02130 a2200601 4500
005			20250514042041.0
264		0	_c20021121
008			200211s 0 0 eng d
022			_a0923-7534
024	7		_a10.1093/annonc/mdf253 _2doi
040			_aNLM _beng _cNLM
100	1		_aMead, G M
245	0	0	_aAn international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2002
300			_a1264-74 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBurkitt Lymphoma _xdrug therapy
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aCytarabine _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Evaluation
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIfosfamide _xtherapeutic use
650	0	4	_aL-Lactate Dehydrogenase _xmetabolism
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aRisk Factors
650	0	4	_aSurvival Rate
650	0	4	_aTreatment Outcome
650	0	4	_aUnited Kingdom
650	0	4	_aVincristine _xtherapeutic use
700	1		_aSydes, M R
700	1		_aWalewski, J
700	1		_aGrigg, A
700	1		_aHatton, C S
700	1		_aPescosta, N
700	1		_aGuarnaccia, C
700	1		_aLewis, M S
700	1		_aMcKendrick, J
700	1		_aStenning, S P
700	1		_aWright, D
700	1		_aNorbert, P
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 13 _gno. 8 _gp. 1264-74
856	4	0	_uhttps://doi.org/10.1093/annonc/mdf253 _zAvailable from publisher's website
999			_c12063738 _d12063738